Just because a business does not make any money, does not mean that the stock will go down. Indeed, NeuroMetrix (NASDAQ:NURO) stock is up 920% in the last year, providing strong gains for shareholders ...
NeuroMetrix Inc (NASDAQ: NURO) shares are surging higher Friday on abnormally high volume amid an increase in retail investor interest around the low-float stock. The average session volume is just ...
WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. ("NeuroMetrix” or the "Company”) (Nasdaq: NURO) today announced it has entered into a ...
On December 2, Bradley Fluegel notified the Board of Directors of NeuroMetrix (NURO), of his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of December ...
The NeuroMetrix team has proven that it can successfully commercialize medical device products through its highly capable team, including its sales force. I personally look forward to carrying out the ...
Shares have lost half their value since this spring as a number of insurers have said they would restrict reimbursement for the company's nerve tests. But some investors are betting doctors who find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results